{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:35:04Z","timestamp":1790094904406,"version":"4.0.1"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,28]]},"abstract":"<jats:p>As a multifactorial degenerative disease, Parkinson disease (PD) causes tremor, gait rigidity, and hypokinesia, which interfere with normal life. Because the disease is usually discovered in the late stage of complete degeneration of neurons, it can greatly delay treatment and even eventually lead to death. Therefore, the diagnosis of this disease is very challenging, and it is gratifying that substantial progress has been made in the development of optical coherence tomography (OCT) as a diagnostic biomarker for this disease, and genetic and imaging tests have become part of routine protocols in clinical practice. In the cognition of traditional Chinese medicine (TCM), this disease belongs to deficiency in origin and excess in superficiality, which is always caused by deficiency of liver and kidney, deficiency of qi and blood, and is closely related to wind, fire, phlegm and blood stasis. A large number of studies have shown that TCM can effectively treat motor and non-motor symptoms of PD, combat oxidative stress and reduce inflammatory response, and improve the quality of life of patients. Based on the pathophysiological mechanism of PD, this paper discusses the treatment of PD by TCM acupuncture combined with medicine based on syndrome differentiation.<\/jats:p>","DOI":"10.1097\/md.0000000000034278","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T22:11:23Z","timestamp":1696630283000},"page":"e34278","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of Parkinson disease by acupuncture combined with medicine based on syndrome differentiation from the perspective of modern medicine: A review"],"prefix":"10.1097","volume":"102","author":[{"given":"Xue","family":"Xia","sequence":"first","affiliation":[{"name":"Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Dong","sequence":"additional","affiliation":[{"name":"Second Affiliated Hospital of Heilongjiang Traditional Chinese Medicine, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqing","family":"Li","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Song","sequence":"additional","affiliation":[{"name":"Second Affiliated Hospital of Heilongjiang Traditional Chinese Medicine, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Tong","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Han","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5273-1145","authenticated-orcid":false,"given":"Dongyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China"},{"name":"Second Affiliated Hospital of Heilongjiang Traditional Chinese Medicine, Harbin, Heilongjiang Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016.","volume":"18","year":"2019","journal-title":"Lancet Neurol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","article-title":"Biomarkers for Parkinson\u2019s disease: recent advancement.","volume":"33","author":"Lotankar","year":"2017","journal-title":"Neurosci Bull"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1590\/0004-282X20160126","article-title":"Unusual motor and non-motor symptoms and signs in the early stage of Parkinson\u2019s disease.","volume":"74","author":"Teive","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages).","author":"Braak","year":"2002","journal-title":"J Neurol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms.","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JPD-191683","article-title":"Parkinson\u2019s disease in women and men: what\u2019s the difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s disease and parkinsonism.","volume":"132","author":"Hayes","year":"2019","journal-title":"Am J Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease.","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"124","author":"Tysnes","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"R11-20250504","doi-asserted-by":"crossref","DOI":"10.1111\/ene.12733","article-title":"Non-motor symptoms burden in treated and untreated early Parkinson\u2019s disease patients: argument for non-motor subtypes.","author":"Zis","year":"2015","journal-title":"Eur J Neurol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/bs.irn.2017.05.023","article-title":"Quality of life and nonmotor symptoms in Parkinson\u2019s disease.","volume":"133","author":"Erro","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1007\/s00415-002-1301-4","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages).","volume":"249","author":"Braak","year":"2002","journal-title":"J Neurol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1474-4422(14)70287-X","article-title":"Prediagnostic presentations of Parkinson\u2019s disease in primary care: a case-control study.","volume":"14","author":"Schrag","year":"2015","journal-title":"Lancet Neurol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(16)00060-0","article-title":"Challenges of modifying disease progression in prediagnostic Parkinson\u2019s disease.","author":"Salat","year":"2016","journal-title":"Lancet Neurol"},{"key":"R16-20250504","article-title":"The genetic architecture of Parkinson\u2019s disease.","volume":"19","author":"Blauwendraat","year":"2019","journal-title":"Lancet Neurol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies.","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"R18-20250504","article-title":"Biomarkers in Parkinson\u2019s disease: advances and strategies.","volume":"22","author":"Delenclos","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","article-title":"Biomarkers in Parkinson\u2019s disease (recent update).","volume":"63","author":"Sharma","year":"2013","journal-title":"Neurochem Int"},{"key":"R21-20250504","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A4049","article-title":"Transcranial sonography of the substantia nigra: digital image analysis.","author":"\u0160koloud\u00edk","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"key":"R22-20250504","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002613","article-title":"Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson\u2019s disease: prospective cohort study in 196 patients.","volume":"3","author":"Bouwmans","year":"2013","journal-title":"BMJ Open"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","article-title":"The relevance of iron in the pathogenesis of Parkinson\u2019s disease.","volume":"118","author":"Sian-H\u00fclsmann","year":"2011","journal-title":"J Neurochem"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"581256","DOI":"10.1155\/2014\/581256","article-title":"Nigral iron elevation is an invariable feature of Parkinson\u2019s disease and is a sufficient cause of neurodegeneration.","volume":"2014","author":"Ayton","year":"2014","journal-title":"Biomed Res Int"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1756285613511507","article-title":"A review of the use of magnetic resonance imaging in Parkinson\u2019s disease.","volume":"7","author":"Pyatigorskaya","year":"2014","journal-title":"Ther Adv Neurol Disord"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"8503859","DOI":"10.1155\/2016\/8503859","article-title":"Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases.","volume":"2016","author":"Satue","year":"2016","journal-title":"J Ophthalmol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0346-z","article-title":"The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson\u2019s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.","volume":"4","author":"Normando","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","article-title":"Cerebrospinal fluid biomarkers in Parkinson disease.","volume":"9","author":"Parnetti","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"R30-20250504","first-page":"369","article-title":"Cerebrospinal fluid biochemical studies in patients with Parkinson\u2019s disease: toward a potential search for biomarkers for this disease.","volume":"8","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"100661","DOI":"10.1016\/j.xcrm.2022.100661","article-title":"Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson\u2019s disease.","volume":"3","author":"Karayel","year":"2022","journal-title":"Cell Rep Med"},{"key":"R32-20250504","article-title":"Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson\u2019s disease patients with mild cognitive impairment.","volume":"9","author":"Alberto","year":"2015","journal-title":"Front Behav Neurosci"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jns.2016.01.032","article-title":"Relationship of circulatory BDNF with cognitive deficits in people with Parkinson\u2019s disease.","volume":"362","author":"Khalil","year":"2016","journal-title":"J Neurol Sci"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1002\/mds.28779","article-title":"Neurofilament light chain as a biomarker for cognitive decline in parkinson disease.","volume":"36","author":"Aamodt","year":"2021","journal-title":"Mov Disord"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1007\/s12035-020-02035-9","article-title":"Different clinical contexts of use of blood neurofilament light chain protein in the spectrum of neurodegenerative diseases.","volume":"57","author":"Palermo","year":"2020","journal-title":"Mol Neurobiol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/jnnp-2013-307539","article-title":"Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions.","volume":"85","author":"Magdalinou","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R37-20250504","first-page":"2109","article-title":"Expert consensus on clinical diagnosis and treatment of Parkinson\u2019s disease (Tremor\u2019s disease) in traditional Chinese medicine.","volume":"62","author":"Xiaodong","year":"2021","journal-title":"J Tradit Chin Med"},{"key":"R38-20250504","first-page":"142","article-title":"Analysis of the academic value of Chishui Xuanzhu complete works.","volume":"19","author":"Meng","year":"2022","journal-title":"China Med News"},{"key":"R39-20250504","first-page":"1486","article-title":"Clinical study on the regularity of syndromes of parkinson\u2019s disease.","volume":"12","author":"Huo","year":"2017","journal-title":"World J Integr Tradit Chin West Med"},{"key":"R40-20250504","first-page":"311","article-title":"Analysis of TCM syndromes of Parkinson\u2019s disease.","volume":"37","author":"Zhao","year":"2016","journal-title":"Shaanxi Tradit Chin Med"},{"key":"R41-20250504","first-page":"3216","article-title":"Study on TCM basic syndromes of Parkinson\u2019s disease based on clinical case literature.","volume":"31","author":"Chen","year":"2016","journal-title":"Chin J Tradit Chin Med"},{"key":"R42-20250504","first-page":"285","article-title":"Analysis of TCM syndrome characteristics of 350 patients with Parkinson\u2019s disease.","volume":"34","author":"Yang","year":"2018","journal-title":"J Changchun Univ Tradit Chin Med"},{"key":"R43-20250504","first-page":"1306","article-title":"Effect of Zhichan decoction on intestinal flora in patients with Parkinson\u2019s disease of liver-kidney deficiency syndrome: a randomized controlled study.","volume":"43","author":"Xu","year":"2022","journal-title":"World Clin Med"},{"key":"R44-20250504","first-page":"2418","article-title":"Effect of Pingchan Shujin decoction on dopamine, neurotrophic factors and inflammatory factors in patients with early parkinson\u2019s disease.","volume":"31","author":"Song","year":"2022","journal-title":"J Integr Tradit Chin West Med"},{"key":"R45-20250504","first-page":"1346","article-title":"Clinical efficacy of Yangxin Dingji capsule in the treatment of Parkinson\u2019s disease with depression and its effects on PI3K, AKT and mTOR protein levels.","volume":"17","author":"Han","year":"2022","journal-title":"World J Integr Chin West Med"},{"key":"R46-20250504","first-page":"1323","article-title":"Research progress on clinical efficacy and mechanism of acupuncture in treatment of Parkinson\u2019s disease.","volume":"44","author":"Liu","year":"2022","journal-title":"Int J Tradit Chin Med"},{"key":"R47-20250504","first-page":"993","article-title":"Effects of early electroacupuncture intervention on the expression of ionized calcium adaptor protein-1 and tumor necrosis factor-\u03b1 in mice with Parkinson\u2019s disease.","volume":"47","author":"Ma","year":"2022","journal-title":"Acupunct Res"},{"key":"R48-20250504","first-page":"1","article-title":"Effects of electroacupuncture on hippocampal synaptic plasticity and complement dependent memory impairment in dementia mice with Parkinson\u2019s disease.","author":"Guo","journal-title":"Acupunct Stud"},{"key":"R49-20250504","first-page":"983","article-title":"Effect of electroacupuncture on apoptosis of dopaminergic neurons in rats with Parkinson\u2019s disease by regulating NLRP3\/Caspase-1 pathway.","volume":"47","author":"Liu","year":"2022","journal-title":"Acupunct Res"},{"key":"R50-20250504","first-page":"2211","article-title":"Clinical observation on treatment of Parkinson\u2019s disease with Linggui Bafa moxibustion.","volume":"33","author":"Zhang","year":"2022","journal-title":"Shi Zhen Guo Yi Guo Yao"},{"key":"R51-20250504","first-page":"36","article-title":"Effect of Sangzhen Yangshen recipe combined with acupuncture and levodopa and benserazide tablets on clinical indexes of parkinson\u2019s disease with liver-kidney yin deficiency syndrome.","volume":"35","author":"Liu","year":"2022","journal-title":"Chin Med Res"},{"key":"R52-20250504","first-page":"1","article-title":"Effect of Bushen Zhichan decoction combined with acupuncture on sleep disorder of Parkinson\u2019s disease and its influence on blood glutamic acid and cystatin C.","author":"Song","journal-title":"Chin J Tradit Chin Med"},{"key":"R53-20250504","first-page":"248","article-title":"clinical efficacy of mind-regulating acupuncture therapy combined with Bushen Huoxue Shugan decoction in treating Parkinson\u2019s disease with depression.","volume":"40","author":"Cai","year":"2022","journal-title":"Chin J Tradit Chin Med"},{"key":"R54-20250504","first-page":"63","article-title":"Clinical study on rehmannia-yin-nourishing and kidney-tonifying decoction combined with acupuncture in treating parkinson\u2019s disease with liver and kidney deficiency syndrome.","volume":"54","author":"Wang","year":"2022","journal-title":"New Chin Med"},{"key":"R55-20250504","first-page":"6431","article-title":"Study on the birth luck and prevalence trend of 13878 patients with Parkinson\u2019s disease.","volume":"36","author":"Xuelin","year":"2021","journal-title":"Chin J Tradit Chin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:07:12Z","timestamp":1746324432000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":53,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034278","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}